Global Nucleic Acid-based Drugs Market Research Report 2026(Status and Outlook)
Nucleic acid-based drugs are a new generation of biologics that use nucleic acids—including but not limited to antisense oligonucleotides (ASOs), siRNA, mRNA, aptamers, and gene-editing vectors—as active ingredients to modulate gene expression or directly replace/modify genetic information for therapeutic effect. Unlike conventional small molecules or protein therapeutics, nucleic acid drugs can intervene at the molecular root of disease with high target specificity and sequence designability, enabling access to historically “undruggable” targets. In recent years, advances in mRNA platforms, modified nucleotides, and delivery systems (such as lipid nanoparticles) have significantly accelerated clinical translation and industrial-scale manufacturing, moving the field rapidly from research-driven innovation toward commercialization and making it a core disruptive track in the pharmaceutical industry.Opportunities in the nucleic acid drug sector stem from the convergence of technology and policy: platform advancements in mRNA, chemical nucleotide modification, and LNP delivery have shortened development timelines and expanded potential indications; regulatory acceptance and public-health prioritization have integrated nucleic acid products into national biopharmaceutical strategies, generating policy and procurement support. Meanwhile, sustained capital inflows and the commercial success of approved nucleic acid therapies are building an end-to-end ecosystem—from upstream materials and CMC to downstream distribution—creating immediate market expansion opportunities for companies with robust platforms and regulatory experience. Despite promising prospects, commercialization faces material risks: delivery efficiency, tissue-specific targeting, and long-term safety require extensive clinical validation; upstream supply concentration and quality consistency of critical materials (modified nucleotides, lipid components, enzymes) challenge manufacturing resilience; regulatory heterogeneity and reimbursement/price uncertainties can slow adoption. Intensifying competition further means that without differentiated platforms and reliable manufacturing capability, new entrants will struggle to secure sustainable market positions. Downstream demand is expanding from research and early clinical use to broader therapeutic and prophylactic applications. Clinically, rare diseases, genetic/metabolic disorders, oncology, and infectious disease vaccines drive strong demand for nucleic acid therapeutics; market-wise, healthcare institutions, specialty treatment centers, and commercial distribution networks are scaling to support chronic administration and cold-chain logistics; payer and buyer behavior is shifting from pilot or grant-driven uptake to value-driven procurement, with an increased focus on real-world effectiveness, cost-effectiveness, and accessibility—factors that will amplify demand for standardized, scalable nucleic acid formulations.Key upstream inputs for nucleic acid drugs include synthesized and modified nucleotides, carrier materials (e.g., LNP components), high-purity enzymes and reagents, and GMP-grade consumables and equipment. As mRNA and siRNA products move to large-scale production, upstream requirements for quality, traceability, and batch consistency intensify, driving higher supplier concentration and the need for long-term supply agreements. Geographic dependencies and geopolitical risks are incentivizing companies to pursue localization and strategic inventory to ensure supply continuity and manufacturing resilience.The average gross profit margin of this product is 85%.
The global Nucleic Acid-based Drugs market size was estimated at USD 14636.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 7.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Nucleic Acid-based Drugs market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Nucleic Acid-based Drugs market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Nucleic Acid-based Drugs market.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Nucleic Acid-based Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Nucleic Acid-based Drugs, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
The global Nucleic Acid-based Drugs market size was estimated at USD 14636.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 7.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Nucleic Acid-based Drugs market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Nucleic Acid-based Drugs market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Nucleic Acid-based Drugs market.
Global Nucleic Acid-based Drugs Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
- Sarepta Therapeutics
- Ionis Pharmaceuticals
- Alnylam
- Biogen
- Nippon Shinyaku
- Sobi
- Novartis
- BioNTech
- Pfizer
- Moderna Therapeutics
- Jazz Pharmaceuticals
- Novo Nordisk
- AstraZeneca
- Astellas Pharma
Market Segmentation (by Type)
- Antisense Oligonucleotides (ASO)
- siRNA
- mRNA
- Other
Market Segmentation (by Application)
- Neuromuscular Diseases
- hATTR
- COVID-19
- Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Nucleic Acid-based Drugs Market
Overview of the regional outlook of the Nucleic Acid-based Drugs Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Nucleic Acid-based Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Nucleic Acid-based Drugs, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Nucleic Acid-based Drugs
1.2 Key Market Segments
1.2.1 Nucleic Acid-based Drugs Segment by Type
1.2.2 Nucleic Acid-based Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NUCLEIC ACID-BASED DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Nucleic Acid-based Drugs Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Nucleic Acid-based Drugs Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NUCLEIC ACID-BASED DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Nucleic Acid-based Drugs Product Life Cycle
3.3 Global Nucleic Acid-based Drugs Sales by Manufacturers (2020-2025)
3.4 Global Nucleic Acid-based Drugs Revenue Market Share by Manufacturers (2020-2025)
3.5 Nucleic Acid-based Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Nucleic Acid-based Drugs Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Nucleic Acid-based Drugs Market Competitive Situation and Trends
3.8.1 Nucleic Acid-based Drugs Market Concentration Rate
3.8.2 Global 5 and 10 Largest Nucleic Acid-based Drugs Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 NUCLEIC ACID-BASED DRUGS INDUSTRY CHAIN ANALYSIS
4.1 Nucleic Acid-based Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NUCLEIC ACID-BASED DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Nucleic Acid-based Drugs Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to Nucleic Acid-based Drugs Market
5.7 ESG Ratings of Leading Companies
6 NUCLEIC ACID-BASED DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Nucleic Acid-based Drugs Sales Market Share by Type (2020-2025)
6.3 Global Nucleic Acid-based Drugs Market Size by Type (2020-2025)
6.4 Global Nucleic Acid-based Drugs Price by Type (2020-2025)
7 NUCLEIC ACID-BASED DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Nucleic Acid-based Drugs Market Sales by Application (2020-2025)
7.3 Global Nucleic Acid-based Drugs Market Size (M USD) by Application (2020-2025)
7.4 Global Nucleic Acid-based Drugs Sales Growth Rate by Application (2020-2025)
8 NUCLEIC ACID-BASED DRUGS MARKET SALES BY REGION
8.1 Global Nucleic Acid-based Drugs Sales by Region
8.1.1 Global Nucleic Acid-based Drugs Sales by Region
8.1.2 Global Nucleic Acid-based Drugs Sales Market Share by Region
8.2 Global Nucleic Acid-based Drugs Market Size by Region
8.2.1 Global Nucleic Acid-based Drugs Market Size by Region
8.2.2 Global Nucleic Acid-based Drugs Market Size by Region
8.3 North America
8.3.1 North America Nucleic Acid-based Drugs Sales by Country
8.3.2 North America Nucleic Acid-based Drugs Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Nucleic Acid-based Drugs Sales by Country
8.4.2 Europe Nucleic Acid-based Drugs Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Nucleic Acid-based Drugs Sales by Region
8.5.2 Asia Pacific Nucleic Acid-based Drugs Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Nucleic Acid-based Drugs Sales by Country
8.6.2 South America Nucleic Acid-based Drugs Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Nucleic Acid-based Drugs Sales by Region
8.7.2 Middle East and Africa Nucleic Acid-based Drugs Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 NUCLEIC ACID-BASED DRUGS MARKET PRODUCTION BY REGION
9.1 Global Production of Nucleic Acid-based Drugs by Region(2020-2025)
9.2 Global Nucleic Acid-based Drugs Revenue Market Share by Region (2020-2025)
9.3 Global Nucleic Acid-based Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Nucleic Acid-based Drugs Production
9.4.1 North America Nucleic Acid-based Drugs Production Growth Rate (2020-2025)
9.4.2 North America Nucleic Acid-based Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Nucleic Acid-based Drugs Production
9.5.1 Europe Nucleic Acid-based Drugs Production Growth Rate (2020-2025)
9.5.2 Europe Nucleic Acid-based Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Nucleic Acid-based Drugs Production (2020-2025)
9.6.1 Japan Nucleic Acid-based Drugs Production Growth Rate (2020-2025)
9.6.2 Japan Nucleic Acid-based Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Nucleic Acid-based Drugs Production (2020-2025)
9.7.1 China Nucleic Acid-based Drugs Production Growth Rate (2020-2025)
9.7.2 China Nucleic Acid-based Drugs Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Sarepta Therapeutics
10.1.1 Sarepta Therapeutics Basic Information
10.1.2 Sarepta Therapeutics Nucleic Acid-based Drugs Product Overview
10.1.3 Sarepta Therapeutics Nucleic Acid-based Drugs Product Market Performance
10.1.4 Sarepta Therapeutics Business Overview
10.1.5 Sarepta Therapeutics SWOT Analysis
10.1.6 Sarepta Therapeutics Recent Developments
10.2 Ionis Pharmaceuticals
10.2.1 Ionis Pharmaceuticals Basic Information
10.2.2 Ionis Pharmaceuticals Nucleic Acid-based Drugs Product Overview
10.2.3 Ionis Pharmaceuticals Nucleic Acid-based Drugs Product Market Performance
10.2.4 Ionis Pharmaceuticals Business Overview
10.2.5 Ionis Pharmaceuticals SWOT Analysis
10.2.6 Ionis Pharmaceuticals Recent Developments
10.3 Alnylam
10.3.1 Alnylam Basic Information
10.3.2 Alnylam Nucleic Acid-based Drugs Product Overview
10.3.3 Alnylam Nucleic Acid-based Drugs Product Market Performance
10.3.4 Alnylam Business Overview
10.3.5 Alnylam SWOT Analysis
10.3.6 Alnylam Recent Developments
10.4 Biogen
10.4.1 Biogen Basic Information
10.4.2 Biogen Nucleic Acid-based Drugs Product Overview
10.4.3 Biogen Nucleic Acid-based Drugs Product Market Performance
10.4.4 Biogen Business Overview
10.4.5 Biogen Recent Developments
10.5 Nippon Shinyaku
10.5.1 Nippon Shinyaku Basic Information
10.5.2 Nippon Shinyaku Nucleic Acid-based Drugs Product Overview
10.5.3 Nippon Shinyaku Nucleic Acid-based Drugs Product Market Performance
10.5.4 Nippon Shinyaku Business Overview
10.5.5 Nippon Shinyaku Recent Developments
10.6 Sobi
10.6.1 Sobi Basic Information
10.6.2 Sobi Nucleic Acid-based Drugs Product Overview
10.6.3 Sobi Nucleic Acid-based Drugs Product Market Performance
10.6.4 Sobi Business Overview
10.6.5 Sobi Recent Developments
10.7 Novartis
10.7.1 Novartis Basic Information
10.7.2 Novartis Nucleic Acid-based Drugs Product Overview
10.7.3 Novartis Nucleic Acid-based Drugs Product Market Performance
10.7.4 Novartis Business Overview
10.7.5 Novartis Recent Developments
10.8 BioNTech
10.8.1 BioNTech Basic Information
10.8.2 BioNTech Nucleic Acid-based Drugs Product Overview
10.8.3 BioNTech Nucleic Acid-based Drugs Product Market Performance
10.8.4 BioNTech Business Overview
10.8.5 BioNTech Recent Developments
10.9 Pfizer
10.9.1 Pfizer Basic Information
10.9.2 Pfizer Nucleic Acid-based Drugs Product Overview
10.9.3 Pfizer Nucleic Acid-based Drugs Product Market Performance
10.9.4 Pfizer Business Overview
10.9.5 Pfizer Recent Developments
10.10 Moderna Therapeutics
10.10.1 Moderna Therapeutics Basic Information
10.10.2 Moderna Therapeutics Nucleic Acid-based Drugs Product Overview
10.10.3 Moderna Therapeutics Nucleic Acid-based Drugs Product Market Performance
10.10.4 Moderna Therapeutics Business Overview
10.10.5 Moderna Therapeutics Recent Developments
10.11 Jazz Pharmaceuticals
10.11.1 Jazz Pharmaceuticals Basic Information
10.11.2 Jazz Pharmaceuticals Nucleic Acid-based Drugs Product Overview
10.11.3 Jazz Pharmaceuticals Nucleic Acid-based Drugs Product Market Performance
10.11.4 Jazz Pharmaceuticals Business Overview
10.11.5 Jazz Pharmaceuticals Recent Developments
10.12 Novo Nordisk
10.12.1 Novo Nordisk Basic Information
10.12.2 Novo Nordisk Nucleic Acid-based Drugs Product Overview
10.12.3 Novo Nordisk Nucleic Acid-based Drugs Product Market Performance
10.12.4 Novo Nordisk Business Overview
10.12.5 Novo Nordisk Recent Developments
10.13 AstraZeneca
10.13.1 AstraZeneca Basic Information
10.13.2 AstraZeneca Nucleic Acid-based Drugs Product Overview
10.13.3 AstraZeneca Nucleic Acid-based Drugs Product Market Performance
10.13.4 AstraZeneca Business Overview
10.13.5 AstraZeneca Recent Developments
10.14 Astellas Pharma
10.14.1 Astellas Pharma Basic Information
10.14.2 Astellas Pharma Nucleic Acid-based Drugs Product Overview
10.14.3 Astellas Pharma Nucleic Acid-based Drugs Product Market Performance
10.14.4 Astellas Pharma Business Overview
10.14.5 Astellas Pharma Recent Developments
11 NUCLEIC ACID-BASED DRUGS MARKET FORECAST BY REGION
11.1 Global Nucleic Acid-based Drugs Market Size Forecast
11.2 Global Nucleic Acid-based Drugs Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Nucleic Acid-based Drugs Market Size Forecast by Country
11.2.3 Asia Pacific Nucleic Acid-based Drugs Market Size Forecast by Region
11.2.4 South America Nucleic Acid-based Drugs Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Nucleic Acid-based Drugs by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Nucleic Acid-based Drugs Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Nucleic Acid-based Drugs by Type (2026-2035)
12.1.2 Global Nucleic Acid-based Drugs Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Nucleic Acid-based Drugs by Type (2026-2035)
12.2 Global Nucleic Acid-based Drugs Market Forecast by Application (2026-2035)
12.2.1 Global Nucleic Acid-based Drugs Sales (K Units) Forecast by Application
12.2.2 Global Nucleic Acid-based Drugs Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Nucleic Acid-based Drugs
1.2 Key Market Segments
1.2.1 Nucleic Acid-based Drugs Segment by Type
1.2.2 Nucleic Acid-based Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NUCLEIC ACID-BASED DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Nucleic Acid-based Drugs Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Nucleic Acid-based Drugs Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NUCLEIC ACID-BASED DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Nucleic Acid-based Drugs Product Life Cycle
3.3 Global Nucleic Acid-based Drugs Sales by Manufacturers (2020-2025)
3.4 Global Nucleic Acid-based Drugs Revenue Market Share by Manufacturers (2020-2025)
3.5 Nucleic Acid-based Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Nucleic Acid-based Drugs Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Nucleic Acid-based Drugs Market Competitive Situation and Trends
3.8.1 Nucleic Acid-based Drugs Market Concentration Rate
3.8.2 Global 5 and 10 Largest Nucleic Acid-based Drugs Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 NUCLEIC ACID-BASED DRUGS INDUSTRY CHAIN ANALYSIS
4.1 Nucleic Acid-based Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NUCLEIC ACID-BASED DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Nucleic Acid-based Drugs Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to Nucleic Acid-based Drugs Market
5.7 ESG Ratings of Leading Companies
6 NUCLEIC ACID-BASED DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Nucleic Acid-based Drugs Sales Market Share by Type (2020-2025)
6.3 Global Nucleic Acid-based Drugs Market Size by Type (2020-2025)
6.4 Global Nucleic Acid-based Drugs Price by Type (2020-2025)
7 NUCLEIC ACID-BASED DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Nucleic Acid-based Drugs Market Sales by Application (2020-2025)
7.3 Global Nucleic Acid-based Drugs Market Size (M USD) by Application (2020-2025)
7.4 Global Nucleic Acid-based Drugs Sales Growth Rate by Application (2020-2025)
8 NUCLEIC ACID-BASED DRUGS MARKET SALES BY REGION
8.1 Global Nucleic Acid-based Drugs Sales by Region
8.1.1 Global Nucleic Acid-based Drugs Sales by Region
8.1.2 Global Nucleic Acid-based Drugs Sales Market Share by Region
8.2 Global Nucleic Acid-based Drugs Market Size by Region
8.2.1 Global Nucleic Acid-based Drugs Market Size by Region
8.2.2 Global Nucleic Acid-based Drugs Market Size by Region
8.3 North America
8.3.1 North America Nucleic Acid-based Drugs Sales by Country
8.3.2 North America Nucleic Acid-based Drugs Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Nucleic Acid-based Drugs Sales by Country
8.4.2 Europe Nucleic Acid-based Drugs Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Nucleic Acid-based Drugs Sales by Region
8.5.2 Asia Pacific Nucleic Acid-based Drugs Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Nucleic Acid-based Drugs Sales by Country
8.6.2 South America Nucleic Acid-based Drugs Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Nucleic Acid-based Drugs Sales by Region
8.7.2 Middle East and Africa Nucleic Acid-based Drugs Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 NUCLEIC ACID-BASED DRUGS MARKET PRODUCTION BY REGION
9.1 Global Production of Nucleic Acid-based Drugs by Region(2020-2025)
9.2 Global Nucleic Acid-based Drugs Revenue Market Share by Region (2020-2025)
9.3 Global Nucleic Acid-based Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Nucleic Acid-based Drugs Production
9.4.1 North America Nucleic Acid-based Drugs Production Growth Rate (2020-2025)
9.4.2 North America Nucleic Acid-based Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Nucleic Acid-based Drugs Production
9.5.1 Europe Nucleic Acid-based Drugs Production Growth Rate (2020-2025)
9.5.2 Europe Nucleic Acid-based Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Nucleic Acid-based Drugs Production (2020-2025)
9.6.1 Japan Nucleic Acid-based Drugs Production Growth Rate (2020-2025)
9.6.2 Japan Nucleic Acid-based Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Nucleic Acid-based Drugs Production (2020-2025)
9.7.1 China Nucleic Acid-based Drugs Production Growth Rate (2020-2025)
9.7.2 China Nucleic Acid-based Drugs Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Sarepta Therapeutics
10.1.1 Sarepta Therapeutics Basic Information
10.1.2 Sarepta Therapeutics Nucleic Acid-based Drugs Product Overview
10.1.3 Sarepta Therapeutics Nucleic Acid-based Drugs Product Market Performance
10.1.4 Sarepta Therapeutics Business Overview
10.1.5 Sarepta Therapeutics SWOT Analysis
10.1.6 Sarepta Therapeutics Recent Developments
10.2 Ionis Pharmaceuticals
10.2.1 Ionis Pharmaceuticals Basic Information
10.2.2 Ionis Pharmaceuticals Nucleic Acid-based Drugs Product Overview
10.2.3 Ionis Pharmaceuticals Nucleic Acid-based Drugs Product Market Performance
10.2.4 Ionis Pharmaceuticals Business Overview
10.2.5 Ionis Pharmaceuticals SWOT Analysis
10.2.6 Ionis Pharmaceuticals Recent Developments
10.3 Alnylam
10.3.1 Alnylam Basic Information
10.3.2 Alnylam Nucleic Acid-based Drugs Product Overview
10.3.3 Alnylam Nucleic Acid-based Drugs Product Market Performance
10.3.4 Alnylam Business Overview
10.3.5 Alnylam SWOT Analysis
10.3.6 Alnylam Recent Developments
10.4 Biogen
10.4.1 Biogen Basic Information
10.4.2 Biogen Nucleic Acid-based Drugs Product Overview
10.4.3 Biogen Nucleic Acid-based Drugs Product Market Performance
10.4.4 Biogen Business Overview
10.4.5 Biogen Recent Developments
10.5 Nippon Shinyaku
10.5.1 Nippon Shinyaku Basic Information
10.5.2 Nippon Shinyaku Nucleic Acid-based Drugs Product Overview
10.5.3 Nippon Shinyaku Nucleic Acid-based Drugs Product Market Performance
10.5.4 Nippon Shinyaku Business Overview
10.5.5 Nippon Shinyaku Recent Developments
10.6 Sobi
10.6.1 Sobi Basic Information
10.6.2 Sobi Nucleic Acid-based Drugs Product Overview
10.6.3 Sobi Nucleic Acid-based Drugs Product Market Performance
10.6.4 Sobi Business Overview
10.6.5 Sobi Recent Developments
10.7 Novartis
10.7.1 Novartis Basic Information
10.7.2 Novartis Nucleic Acid-based Drugs Product Overview
10.7.3 Novartis Nucleic Acid-based Drugs Product Market Performance
10.7.4 Novartis Business Overview
10.7.5 Novartis Recent Developments
10.8 BioNTech
10.8.1 BioNTech Basic Information
10.8.2 BioNTech Nucleic Acid-based Drugs Product Overview
10.8.3 BioNTech Nucleic Acid-based Drugs Product Market Performance
10.8.4 BioNTech Business Overview
10.8.5 BioNTech Recent Developments
10.9 Pfizer
10.9.1 Pfizer Basic Information
10.9.2 Pfizer Nucleic Acid-based Drugs Product Overview
10.9.3 Pfizer Nucleic Acid-based Drugs Product Market Performance
10.9.4 Pfizer Business Overview
10.9.5 Pfizer Recent Developments
10.10 Moderna Therapeutics
10.10.1 Moderna Therapeutics Basic Information
10.10.2 Moderna Therapeutics Nucleic Acid-based Drugs Product Overview
10.10.3 Moderna Therapeutics Nucleic Acid-based Drugs Product Market Performance
10.10.4 Moderna Therapeutics Business Overview
10.10.5 Moderna Therapeutics Recent Developments
10.11 Jazz Pharmaceuticals
10.11.1 Jazz Pharmaceuticals Basic Information
10.11.2 Jazz Pharmaceuticals Nucleic Acid-based Drugs Product Overview
10.11.3 Jazz Pharmaceuticals Nucleic Acid-based Drugs Product Market Performance
10.11.4 Jazz Pharmaceuticals Business Overview
10.11.5 Jazz Pharmaceuticals Recent Developments
10.12 Novo Nordisk
10.12.1 Novo Nordisk Basic Information
10.12.2 Novo Nordisk Nucleic Acid-based Drugs Product Overview
10.12.3 Novo Nordisk Nucleic Acid-based Drugs Product Market Performance
10.12.4 Novo Nordisk Business Overview
10.12.5 Novo Nordisk Recent Developments
10.13 AstraZeneca
10.13.1 AstraZeneca Basic Information
10.13.2 AstraZeneca Nucleic Acid-based Drugs Product Overview
10.13.3 AstraZeneca Nucleic Acid-based Drugs Product Market Performance
10.13.4 AstraZeneca Business Overview
10.13.5 AstraZeneca Recent Developments
10.14 Astellas Pharma
10.14.1 Astellas Pharma Basic Information
10.14.2 Astellas Pharma Nucleic Acid-based Drugs Product Overview
10.14.3 Astellas Pharma Nucleic Acid-based Drugs Product Market Performance
10.14.4 Astellas Pharma Business Overview
10.14.5 Astellas Pharma Recent Developments
11 NUCLEIC ACID-BASED DRUGS MARKET FORECAST BY REGION
11.1 Global Nucleic Acid-based Drugs Market Size Forecast
11.2 Global Nucleic Acid-based Drugs Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Nucleic Acid-based Drugs Market Size Forecast by Country
11.2.3 Asia Pacific Nucleic Acid-based Drugs Market Size Forecast by Region
11.2.4 South America Nucleic Acid-based Drugs Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Nucleic Acid-based Drugs by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Nucleic Acid-based Drugs Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Nucleic Acid-based Drugs by Type (2026-2035)
12.1.2 Global Nucleic Acid-based Drugs Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Nucleic Acid-based Drugs by Type (2026-2035)
12.2 Global Nucleic Acid-based Drugs Market Forecast by Application (2026-2035)
12.2.1 Global Nucleic Acid-based Drugs Sales (K Units) Forecast by Application
12.2.2 Global Nucleic Acid-based Drugs Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Nucleic Acid-based Drugs Market Size by Type (M USD)
Table 4. Global Nucleic Acid-based Drugs Market Size by Application
Table 5. Nucleic Acid-based Drugs Market Size Comparison by Region (M USD)
Table 6. Global Nucleic Acid-based Drugs Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Nucleic Acid-based Drugs Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Nucleic Acid-based Drugs Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Nucleic Acid-based Drugs Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid-based Drugs as of 2025)
Table 11. Global Market Nucleic Acid-based Drugs Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Nucleic Acid-based Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Nucleic Acid-based Drugs Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Nucleic Acid-based Drugs Sales by Type (K Units)
Table 27. Global Nucleic Acid-based Drugs Market Size by Type (M USD)
Table 28. Global Nucleic Acid-based Drugs Sales (K Units) by Type (2020-2025)
Table 29. Global Nucleic Acid-based Drugs Sales Market Share by Type (2020-2025)
Table 30. Global Nucleic Acid-based Drugs Market Size (M USD) by Type (2020-2025)
Table 31. Global Nucleic Acid-based Drugs Market Share by Type (2020-2025)
Table 32. Global Nucleic Acid-based Drugs Price (USD/Unit) by Type (2020-2025)
Table 33. Global Nucleic Acid-based Drugs Sales (K Units) by Application
Table 34. Global Nucleic Acid-based Drugs Market Size by Application
Table 35. Global Nucleic Acid-based Drugs Sales by Application (2020-2025) & (K Units)
Table 36. Global Nucleic Acid-based Drugs Sales Market Share by Application (2020-2025)
Table 37. Global Nucleic Acid-based Drugs Market Size by Application (2020-2025) & (M USD)
Table 38. Global Nucleic Acid-based Drugs Market Share by Application (2020-2025)
Table 39. Global Nucleic Acid-based Drugs Sales Growth Rate by Application (2020-2025)
Table 40. Global Nucleic Acid-based Drugs Sales by Region (2020-2025) & (K Units)
Table 41. Global Nucleic Acid-based Drugs Sales Market Share by Region (2020-2025)
Table 42. Global Nucleic Acid-based Drugs Market Size by Region (2020-2025) & (M USD)
Table 43. Global Nucleic Acid-based Drugs Market Size by Region (2020-2025)
Table 44. North America Nucleic Acid-based Drugs Sales by Country (2020-2025) & (K Units)
Table 45. North America Nucleic Acid-based Drugs Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Nucleic Acid-based Drugs Sales by Country (2020-2025) & (K Units)
Table 47. Europe Nucleic Acid-based Drugs Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Nucleic Acid-based Drugs Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Nucleic Acid-based Drugs Market Size by Region (2020-2025) & (M USD)
Table 50. South America Nucleic Acid-based Drugs Sales by Country (2020-2025) & (K Units)
Table 51. South America Nucleic Acid-based Drugs Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Nucleic Acid-based Drugs Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Nucleic Acid-based Drugs Market Size by Region (2020-2025) & (M USD)
Table 54. Global Nucleic Acid-based Drugs Production (K Units) by Region(2020-2025)
Table 55. Global Nucleic Acid-based Drugs Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Nucleic Acid-based Drugs Revenue Market Share by Region (2020-2025)
Table 57. Global Nucleic Acid-based Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Nucleic Acid-based Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Nucleic Acid-based Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Nucleic Acid-based Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Nucleic Acid-based Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Sarepta Therapeutics Basic Information
Table 63. Sarepta Therapeutics Nucleic Acid-based Drugs Product Overview
Table 64. Sarepta Therapeutics Nucleic Acid-based Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Sarepta Therapeutics Business Overview
Table 66. Sarepta Therapeutics SWOT Analysis
Table 67. Sarepta Therapeutics Recent Developments
Table 68. Ionis Pharmaceuticals Basic Information
Table 69. Ionis Pharmaceuticals Nucleic Acid-based Drugs Product Overview
Table 70. Ionis Pharmaceuticals Nucleic Acid-based Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Ionis Pharmaceuticals Business Overview
Table 72. Ionis Pharmaceuticals SWOT Analysis
Table 73. Ionis Pharmaceuticals Recent Developments
Table 74. Alnylam Basic Information
Table 75. Alnylam Nucleic Acid-based Drugs Product Overview
Table 76. Alnylam Nucleic Acid-based Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Alnylam Business Overview
Table 78. Alnylam SWOT Analysis
Table 79. Alnylam Recent Developments
Table 80. Biogen Basic Information
Table 81. Biogen Nucleic Acid-based Drugs Product Overview
Table 82. Biogen Nucleic Acid-based Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Biogen Business Overview
Table 84. Biogen Recent Developments
Table 85. Nippon Shinyaku Basic Information
Table 86. Nippon Shinyaku Nucleic Acid-based Drugs Product Overview
Table 87. Nippon Shinyaku Nucleic Acid-based Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Nippon Shinyaku Business Overview
Table 89. Nippon Shinyaku Recent Developments
Table 90. Sobi Basic Information
Table 91. Sobi Nucleic Acid-based Drugs Product Overview
Table 92. Sobi Nucleic Acid-based Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Sobi Business Overview
Table 94. Sobi Recent Developments
Table 95. Novartis Basic Information
Table 96. Novartis Nucleic Acid-based Drugs Product Overview
Table 97. Novartis Nucleic Acid-based Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Novartis Business Overview
Table 99. Novartis Recent Developments
Table 100. BioNTech Basic Information
Table 101. BioNTech Nucleic Acid-based Drugs Product Overview
Table 102. BioNTech Nucleic Acid-based Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. BioNTech Business Overview
Table 104. BioNTech Recent Developments
Table 105. Pfizer Basic Information
Table 106. Pfizer Nucleic Acid-based Drugs Product Overview
Table 107. Pfizer Nucleic Acid-based Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Pfizer Business Overview
Table 109. Pfizer Recent Developments
Table 110. Moderna Therapeutics Basic Information
Table 111. Moderna Therapeutics Nucleic Acid-based Drugs Product Overview
Table 112. Moderna Therapeutics Nucleic Acid-based Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Moderna Therapeutics Business Overview
Table 114. Moderna Therapeutics Recent Developments
Table 115. Jazz Pharmaceuticals Basic Information
Table 116. Jazz Pharmaceuticals Nucleic Acid-based Drugs Product Overview
Table 117. Jazz Pharmaceuticals Nucleic Acid-based Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Jazz Pharmaceuticals Business Overview
Table 119. Jazz Pharmaceuticals Recent Developments
Table 120. Novo Nordisk Basic Information
Table 121. Novo Nordisk Nucleic Acid-based Drugs Product Overview
Table 122. Novo Nordisk Nucleic Acid-based Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Novo Nordisk Business Overview
Table 124. Novo Nordisk Recent Developments
Table 125. AstraZeneca Basic Information
Table 126. AstraZeneca Nucleic Acid-based Drugs Product Overview
Table 127. AstraZeneca Nucleic Acid-based Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. AstraZeneca Business Overview
Table 129. AstraZeneca Recent Developments
Table 130. Astellas Pharma Basic Information
Table 131. Astellas Pharma Nucleic Acid-based Drugs Product Overview
Table 132. Astellas Pharma Nucleic Acid-based Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Astellas Pharma Business Overview
Table 134. Astellas Pharma Recent Developments
Table 135. Global Nucleic Acid-based Drugs Sales Forecast by Region (2026-2035) & (K Units)
Table 136. Global Nucleic Acid-based Drugs Market Size Forecast by Region (2026-2035) & (M USD)
Table 137. North America Nucleic Acid-based Drugs Sales Forecast by Country (2026-2035) & (K Units)
Table 138. North America Nucleic Acid-based Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 139. Europe Nucleic Acid-based Drugs Sales Forecast by Country (2026-2035) & (K Units)
Table 140. Europe Nucleic Acid-based Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 141. Asia Pacific Nucleic Acid-based Drugs Sales Forecast by Region (2026-2035) & (K Units)
Table 142. Asia Pacific Nucleic Acid-based Drugs Market Size Forecast by Region (2026-2035) & (M USD)
Table 143. South America Nucleic Acid-based Drugs Sales Forecast by Country (2026-2035) & (K Units)
Table 144. South America Nucleic Acid-based Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 145. Middle East and Africa Nucleic Acid-based Drugs Sales Forecast by Country (2026-2035) & (Units)
Table 146. Middle East and Africa Nucleic Acid-based Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 147. Global Nucleic Acid-based Drugs Sales Forecast by Type (2026-2035) & (K Units)
Table 148. Global Nucleic Acid-based Drugs Market Size Forecast by Type (2026-2035) & (M USD)
Table 149. Global Nucleic Acid-based Drugs Price Forecast by Type (2026-2035) & (USD/Unit)
Table 150. Global Nucleic Acid-based Drugs Sales (K Units) Forecast by Application (2026-2035)
Table 151. Global Nucleic Acid-based Drugs Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Nucleic Acid-based Drugs Market Size by Type (M USD)
Table 4. Global Nucleic Acid-based Drugs Market Size by Application
Table 5. Nucleic Acid-based Drugs Market Size Comparison by Region (M USD)
Table 6. Global Nucleic Acid-based Drugs Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Nucleic Acid-based Drugs Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Nucleic Acid-based Drugs Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Nucleic Acid-based Drugs Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid-based Drugs as of 2025)
Table 11. Global Market Nucleic Acid-based Drugs Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Nucleic Acid-based Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Nucleic Acid-based Drugs Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Nucleic Acid-based Drugs Sales by Type (K Units)
Table 27. Global Nucleic Acid-based Drugs Market Size by Type (M USD)
Table 28. Global Nucleic Acid-based Drugs Sales (K Units) by Type (2020-2025)
Table 29. Global Nucleic Acid-based Drugs Sales Market Share by Type (2020-2025)
Table 30. Global Nucleic Acid-based Drugs Market Size (M USD) by Type (2020-2025)
Table 31. Global Nucleic Acid-based Drugs Market Share by Type (2020-2025)
Table 32. Global Nucleic Acid-based Drugs Price (USD/Unit) by Type (2020-2025)
Table 33. Global Nucleic Acid-based Drugs Sales (K Units) by Application
Table 34. Global Nucleic Acid-based Drugs Market Size by Application
Table 35. Global Nucleic Acid-based Drugs Sales by Application (2020-2025) & (K Units)
Table 36. Global Nucleic Acid-based Drugs Sales Market Share by Application (2020-2025)
Table 37. Global Nucleic Acid-based Drugs Market Size by Application (2020-2025) & (M USD)
Table 38. Global Nucleic Acid-based Drugs Market Share by Application (2020-2025)
Table 39. Global Nucleic Acid-based Drugs Sales Growth Rate by Application (2020-2025)
Table 40. Global Nucleic Acid-based Drugs Sales by Region (2020-2025) & (K Units)
Table 41. Global Nucleic Acid-based Drugs Sales Market Share by Region (2020-2025)
Table 42. Global Nucleic Acid-based Drugs Market Size by Region (2020-2025) & (M USD)
Table 43. Global Nucleic Acid-based Drugs Market Size by Region (2020-2025)
Table 44. North America Nucleic Acid-based Drugs Sales by Country (2020-2025) & (K Units)
Table 45. North America Nucleic Acid-based Drugs Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Nucleic Acid-based Drugs Sales by Country (2020-2025) & (K Units)
Table 47. Europe Nucleic Acid-based Drugs Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Nucleic Acid-based Drugs Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Nucleic Acid-based Drugs Market Size by Region (2020-2025) & (M USD)
Table 50. South America Nucleic Acid-based Drugs Sales by Country (2020-2025) & (K Units)
Table 51. South America Nucleic Acid-based Drugs Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Nucleic Acid-based Drugs Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Nucleic Acid-based Drugs Market Size by Region (2020-2025) & (M USD)
Table 54. Global Nucleic Acid-based Drugs Production (K Units) by Region(2020-2025)
Table 55. Global Nucleic Acid-based Drugs Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Nucleic Acid-based Drugs Revenue Market Share by Region (2020-2025)
Table 57. Global Nucleic Acid-based Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Nucleic Acid-based Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Nucleic Acid-based Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Nucleic Acid-based Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Nucleic Acid-based Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Sarepta Therapeutics Basic Information
Table 63. Sarepta Therapeutics Nucleic Acid-based Drugs Product Overview
Table 64. Sarepta Therapeutics Nucleic Acid-based Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Sarepta Therapeutics Business Overview
Table 66. Sarepta Therapeutics SWOT Analysis
Table 67. Sarepta Therapeutics Recent Developments
Table 68. Ionis Pharmaceuticals Basic Information
Table 69. Ionis Pharmaceuticals Nucleic Acid-based Drugs Product Overview
Table 70. Ionis Pharmaceuticals Nucleic Acid-based Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Ionis Pharmaceuticals Business Overview
Table 72. Ionis Pharmaceuticals SWOT Analysis
Table 73. Ionis Pharmaceuticals Recent Developments
Table 74. Alnylam Basic Information
Table 75. Alnylam Nucleic Acid-based Drugs Product Overview
Table 76. Alnylam Nucleic Acid-based Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Alnylam Business Overview
Table 78. Alnylam SWOT Analysis
Table 79. Alnylam Recent Developments
Table 80. Biogen Basic Information
Table 81. Biogen Nucleic Acid-based Drugs Product Overview
Table 82. Biogen Nucleic Acid-based Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Biogen Business Overview
Table 84. Biogen Recent Developments
Table 85. Nippon Shinyaku Basic Information
Table 86. Nippon Shinyaku Nucleic Acid-based Drugs Product Overview
Table 87. Nippon Shinyaku Nucleic Acid-based Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Nippon Shinyaku Business Overview
Table 89. Nippon Shinyaku Recent Developments
Table 90. Sobi Basic Information
Table 91. Sobi Nucleic Acid-based Drugs Product Overview
Table 92. Sobi Nucleic Acid-based Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Sobi Business Overview
Table 94. Sobi Recent Developments
Table 95. Novartis Basic Information
Table 96. Novartis Nucleic Acid-based Drugs Product Overview
Table 97. Novartis Nucleic Acid-based Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Novartis Business Overview
Table 99. Novartis Recent Developments
Table 100. BioNTech Basic Information
Table 101. BioNTech Nucleic Acid-based Drugs Product Overview
Table 102. BioNTech Nucleic Acid-based Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. BioNTech Business Overview
Table 104. BioNTech Recent Developments
Table 105. Pfizer Basic Information
Table 106. Pfizer Nucleic Acid-based Drugs Product Overview
Table 107. Pfizer Nucleic Acid-based Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Pfizer Business Overview
Table 109. Pfizer Recent Developments
Table 110. Moderna Therapeutics Basic Information
Table 111. Moderna Therapeutics Nucleic Acid-based Drugs Product Overview
Table 112. Moderna Therapeutics Nucleic Acid-based Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Moderna Therapeutics Business Overview
Table 114. Moderna Therapeutics Recent Developments
Table 115. Jazz Pharmaceuticals Basic Information
Table 116. Jazz Pharmaceuticals Nucleic Acid-based Drugs Product Overview
Table 117. Jazz Pharmaceuticals Nucleic Acid-based Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Jazz Pharmaceuticals Business Overview
Table 119. Jazz Pharmaceuticals Recent Developments
Table 120. Novo Nordisk Basic Information
Table 121. Novo Nordisk Nucleic Acid-based Drugs Product Overview
Table 122. Novo Nordisk Nucleic Acid-based Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Novo Nordisk Business Overview
Table 124. Novo Nordisk Recent Developments
Table 125. AstraZeneca Basic Information
Table 126. AstraZeneca Nucleic Acid-based Drugs Product Overview
Table 127. AstraZeneca Nucleic Acid-based Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. AstraZeneca Business Overview
Table 129. AstraZeneca Recent Developments
Table 130. Astellas Pharma Basic Information
Table 131. Astellas Pharma Nucleic Acid-based Drugs Product Overview
Table 132. Astellas Pharma Nucleic Acid-based Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Astellas Pharma Business Overview
Table 134. Astellas Pharma Recent Developments
Table 135. Global Nucleic Acid-based Drugs Sales Forecast by Region (2026-2035) & (K Units)
Table 136. Global Nucleic Acid-based Drugs Market Size Forecast by Region (2026-2035) & (M USD)
Table 137. North America Nucleic Acid-based Drugs Sales Forecast by Country (2026-2035) & (K Units)
Table 138. North America Nucleic Acid-based Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 139. Europe Nucleic Acid-based Drugs Sales Forecast by Country (2026-2035) & (K Units)
Table 140. Europe Nucleic Acid-based Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 141. Asia Pacific Nucleic Acid-based Drugs Sales Forecast by Region (2026-2035) & (K Units)
Table 142. Asia Pacific Nucleic Acid-based Drugs Market Size Forecast by Region (2026-2035) & (M USD)
Table 143. South America Nucleic Acid-based Drugs Sales Forecast by Country (2026-2035) & (K Units)
Table 144. South America Nucleic Acid-based Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 145. Middle East and Africa Nucleic Acid-based Drugs Sales Forecast by Country (2026-2035) & (Units)
Table 146. Middle East and Africa Nucleic Acid-based Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 147. Global Nucleic Acid-based Drugs Sales Forecast by Type (2026-2035) & (K Units)
Table 148. Global Nucleic Acid-based Drugs Market Size Forecast by Type (2026-2035) & (M USD)
Table 149. Global Nucleic Acid-based Drugs Price Forecast by Type (2026-2035) & (USD/Unit)
Table 150. Global Nucleic Acid-based Drugs Sales (K Units) Forecast by Application (2026-2035)
Table 151. Global Nucleic Acid-based Drugs Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Nucleic Acid-based Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Nucleic Acid-based Drugs Market Size (M USD), 2025-2035
Figure 5. Global Nucleic Acid-based Drugs Market Size (M USD) (2020-2035)
Figure 6. Global Nucleic Acid-based Drugs Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Nucleic Acid-based Drugs Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Nucleic Acid-based Drugs Product Life Cycle
Figure 13. Nucleic Acid-based Drugs Sales Share by Manufacturers in 2025
Figure 14. Global Nucleic Acid-based Drugs Revenue Share by Manufacturers in 2025
Figure 15. Nucleic Acid-based Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Nucleic Acid-based Drugs Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Nucleic Acid-based Drugs Revenue in 2025
Figure 18. Industry Chain Map of Nucleic Acid-based Drugs
Figure 19. Global Nucleic Acid-based Drugs Market PEST Analysis
Figure 20. Global Nucleic Acid-based Drugs Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Nucleic Acid-based Drugs Market Share by Type
Figure 27. Sales Market Share of Nucleic Acid-based Drugs by Type (2020-2025)
Figure 28. Sales Market Share of Nucleic Acid-based Drugs by Type in 2025
Figure 29. Market Share of Nucleic Acid-based Drugs by Type (2020-2025)
Figure 30. Market Share of Nucleic Acid-based Drugs by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Nucleic Acid-based Drugs Market Share by Application
Figure 33. Global Nucleic Acid-based Drugs Sales Market Share by Application (2020-2025)
Figure 34. Global Nucleic Acid-based Drugs Sales Market Share by Application in 2025
Figure 35. Global Nucleic Acid-based Drugs Market Share by Application (2020-2025)
Figure 36. Global Nucleic Acid-based Drugs Market Share by Application in 2025
Figure 37. Global Nucleic Acid-based Drugs Sales Growth Rate by Application (2020-2025)
Figure 38. Global Nucleic Acid-based Drugs Sales Market Share by Region (2020-2025)
Figure 39. Global Nucleic Acid-based Drugs Market Size by Region (2020-2025)
Figure 40. North America Nucleic Acid-based Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Nucleic Acid-based Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Nucleic Acid-based Drugs Sales Market Share by Country in 2024
Figure 43. North America Nucleic Acid-based Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Nucleic Acid-based Drugs Market Size by Country in 2024
Figure 45. U.S. Nucleic Acid-based Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Nucleic Acid-based Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Nucleic Acid-based Drugs Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Nucleic Acid-based Drugs Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Nucleic Acid-based Drugs Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Nucleic Acid-based Drugs Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Nucleic Acid-based Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Nucleic Acid-based Drugs Sales Market Share by Country in 2024
Figure 53. Europe Nucleic Acid-based Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Nucleic Acid-based Drugs Market Size by Country in 2024
Figure 55. Germany Nucleic Acid-based Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Nucleic Acid-based Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Nucleic Acid-based Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Nucleic Acid-based Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Nucleic Acid-based Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Nucleic Acid-based Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Nucleic Acid-based Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Nucleic Acid-based Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Nucleic Acid-based Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Nucleic Acid-based Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Nucleic Acid-based Drugs Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Nucleic Acid-based Drugs Sales Market Share by Region in 2024
Figure 67. Asia Pacific Nucleic Acid-based Drugs Market Size by Region in 2024
Figure 68. China Nucleic Acid-based Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Nucleic Acid-based Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Nucleic Acid-based Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Nucleic Acid-based Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Nucleic Acid-based Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Nucleic Acid-based Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Nucleic Acid-based Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Nucleic Acid-based Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Nucleic Acid-based Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Nucleic Acid-based Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Nucleic Acid-based Drugs Sales and Growth Rate (K Units)
Figure 79. South America Nucleic Acid-based Drugs Sales Market Share by Country in 2024
Figure 80. South America Nucleic Acid-based Drugs Market Size and Growth Rate (M USD)
Figure 81. South America Nucleic Acid-based Drugs Market Size by Country in 2024
Figure 82. Brazil Nucleic Acid-based Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Nucleic Acid-based Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Nucleic Acid-based Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Nucleic Acid-based Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Nucleic Acid-based Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Nucleic Acid-based Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Nucleic Acid-based Drugs Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Nucleic Acid-based Drugs Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Nucleic Acid-based Drugs Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Nucleic Acid-based Drugs Market Size by Region in 2024
Figure 92. Saudi Arabia Nucleic Acid-based Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Nucleic Acid-based Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Nucleic Acid-based Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Nucleic Acid-based Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Nucleic Acid-based Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Nucleic Acid-based Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Nucleic Acid-based Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Nucleic Acid-based Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Nucleic Acid-based Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Nucleic Acid-based Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Nucleic Acid-based Drugs Production Market Share by Region (2020-2025)
Figure 103. North America Nucleic Acid-based Drugs Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Nucleic Acid-based Drugs Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Nucleic Acid-based Drugs Production (K Units) Growth Rate (2020-2025)
Figure 106. China Nucleic Acid-based Drugs Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Nucleic Acid-based Drugs Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Nucleic Acid-based Drugs Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Nucleic Acid-based Drugs Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Nucleic Acid-based Drugs Market Share Forecast by Type (2026-2035)
Figure 111. Global Nucleic Acid-based Drugs Sales Forecast by Application (2026-2035)
Figure 112. Global Nucleic Acid-based Drugs Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Nucleic Acid-based Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Nucleic Acid-based Drugs Market Size (M USD), 2025-2035
Figure 5. Global Nucleic Acid-based Drugs Market Size (M USD) (2020-2035)
Figure 6. Global Nucleic Acid-based Drugs Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Nucleic Acid-based Drugs Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Nucleic Acid-based Drugs Product Life Cycle
Figure 13. Nucleic Acid-based Drugs Sales Share by Manufacturers in 2025
Figure 14. Global Nucleic Acid-based Drugs Revenue Share by Manufacturers in 2025
Figure 15. Nucleic Acid-based Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Nucleic Acid-based Drugs Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Nucleic Acid-based Drugs Revenue in 2025
Figure 18. Industry Chain Map of Nucleic Acid-based Drugs
Figure 19. Global Nucleic Acid-based Drugs Market PEST Analysis
Figure 20. Global Nucleic Acid-based Drugs Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Nucleic Acid-based Drugs Market Share by Type
Figure 27. Sales Market Share of Nucleic Acid-based Drugs by Type (2020-2025)
Figure 28. Sales Market Share of Nucleic Acid-based Drugs by Type in 2025
Figure 29. Market Share of Nucleic Acid-based Drugs by Type (2020-2025)
Figure 30. Market Share of Nucleic Acid-based Drugs by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Nucleic Acid-based Drugs Market Share by Application
Figure 33. Global Nucleic Acid-based Drugs Sales Market Share by Application (2020-2025)
Figure 34. Global Nucleic Acid-based Drugs Sales Market Share by Application in 2025
Figure 35. Global Nucleic Acid-based Drugs Market Share by Application (2020-2025)
Figure 36. Global Nucleic Acid-based Drugs Market Share by Application in 2025
Figure 37. Global Nucleic Acid-based Drugs Sales Growth Rate by Application (2020-2025)
Figure 38. Global Nucleic Acid-based Drugs Sales Market Share by Region (2020-2025)
Figure 39. Global Nucleic Acid-based Drugs Market Size by Region (2020-2025)
Figure 40. North America Nucleic Acid-based Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Nucleic Acid-based Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Nucleic Acid-based Drugs Sales Market Share by Country in 2024
Figure 43. North America Nucleic Acid-based Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Nucleic Acid-based Drugs Market Size by Country in 2024
Figure 45. U.S. Nucleic Acid-based Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Nucleic Acid-based Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Nucleic Acid-based Drugs Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Nucleic Acid-based Drugs Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Nucleic Acid-based Drugs Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Nucleic Acid-based Drugs Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Nucleic Acid-based Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Nucleic Acid-based Drugs Sales Market Share by Country in 2024
Figure 53. Europe Nucleic Acid-based Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Nucleic Acid-based Drugs Market Size by Country in 2024
Figure 55. Germany Nucleic Acid-based Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Nucleic Acid-based Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Nucleic Acid-based Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Nucleic Acid-based Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Nucleic Acid-based Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Nucleic Acid-based Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Nucleic Acid-based Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Nucleic Acid-based Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Nucleic Acid-based Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Nucleic Acid-based Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Nucleic Acid-based Drugs Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Nucleic Acid-based Drugs Sales Market Share by Region in 2024
Figure 67. Asia Pacific Nucleic Acid-based Drugs Market Size by Region in 2024
Figure 68. China Nucleic Acid-based Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Nucleic Acid-based Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Nucleic Acid-based Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Nucleic Acid-based Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Nucleic Acid-based Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Nucleic Acid-based Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Nucleic Acid-based Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Nucleic Acid-based Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Nucleic Acid-based Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Nucleic Acid-based Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Nucleic Acid-based Drugs Sales and Growth Rate (K Units)
Figure 79. South America Nucleic Acid-based Drugs Sales Market Share by Country in 2024
Figure 80. South America Nucleic Acid-based Drugs Market Size and Growth Rate (M USD)
Figure 81. South America Nucleic Acid-based Drugs Market Size by Country in 2024
Figure 82. Brazil Nucleic Acid-based Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Nucleic Acid-based Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Nucleic Acid-based Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Nucleic Acid-based Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Nucleic Acid-based Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Nucleic Acid-based Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Nucleic Acid-based Drugs Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Nucleic Acid-based Drugs Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Nucleic Acid-based Drugs Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Nucleic Acid-based Drugs Market Size by Region in 2024
Figure 92. Saudi Arabia Nucleic Acid-based Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Nucleic Acid-based Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Nucleic Acid-based Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Nucleic Acid-based Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Nucleic Acid-based Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Nucleic Acid-based Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Nucleic Acid-based Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Nucleic Acid-based Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Nucleic Acid-based Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Nucleic Acid-based Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Nucleic Acid-based Drugs Production Market Share by Region (2020-2025)
Figure 103. North America Nucleic Acid-based Drugs Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Nucleic Acid-based Drugs Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Nucleic Acid-based Drugs Production (K Units) Growth Rate (2020-2025)
Figure 106. China Nucleic Acid-based Drugs Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Nucleic Acid-based Drugs Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Nucleic Acid-based Drugs Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Nucleic Acid-based Drugs Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Nucleic Acid-based Drugs Market Share Forecast by Type (2026-2035)
Figure 111. Global Nucleic Acid-based Drugs Sales Forecast by Application (2026-2035)
Figure 112. Global Nucleic Acid-based Drugs Market Share Forecast by Application (2026-2035)
More Publications
Global Data Center Structured Cabling Service Market Research Report 2026(Status and Outlook)
US$ 2,980.00
February 2026
129 pages
Global Underwater Ultrasonic Sensor Market Research Report 2024(Status and Outlook)
US$ 3,200.00
October 2026
142 pages
Global PRGR Portable Launch Monitor Market Research Report 2026(Status and Outlook)
US$ 3,200.00
May 2026
144 pages
Global Commercial Cryptography Application Security Evaluation Market Research Report 2026(Status and Outlook)
US$ 2,980.00
March 2026
163 pages
Global Intravascular Temperature Management Market Research Report 2026(Status and Outlook)
US$ 3,200.00
May 2026
100 pages
